SG Americas Securities’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $128K | Buy |
+8,028
| New | +$128K | ﹤0.01% | 2244 |
|
|
2024
Q4 | – | Sell |
-15,944
| Closed | -$455K | – | 2892 |
|
|
2024
Q3 | $455K | Sell |
15,944
-14,758
| -48% | -$421K | ﹤0.01% | 1563 |
|
|
2024
Q2 | $811K | Buy |
30,702
+26,546
| +639% | +$701K | ﹤0.01% | 1298 |
|
|
2024
Q1 | $134K | Sell |
4,156
-25,781
| -86% | -$831K | ﹤0.01% | 2059 |
|
|
2023
Q4 | $1.26M | Sell |
29,937
-66,766
| -69% | -$2.81M | 0.01% | 803 |
|
|
2023
Q3 | $3.71M | Buy |
96,703
+50,795
| +111% | +$1.95M | 0.04% | 362 |
|
|
2023
Q2 | $871K | Buy |
45,908
+13,208
| +40% | +$251K | 0.01% | 1002 |
|
|
2023
Q1 | $507K | Buy |
32,700
+11,673
| +56% | +$181K | 0.01% | 1559 |
|
|
2022
Q4 | $373K | Buy |
21,027
+4,323
| +26% | +$76.7K | ﹤0.01% | 1577 |
|
|
2022
Q3 | $93K | Sell |
16,704
-5,918
| -26% | -$32.9K | ﹤0.01% | 2574 |
|
|
2022
Q2 | $88K | Buy |
+22,622
| New | +$88K | ﹤0.01% | 2881 |
|
|
2022
Q1 | – | Sell |
-15,032
| Closed | -$128K | – | 2778 |
|
|
2021
Q4 | $128K | Sell |
15,032
-12,717
| -46% | -$108K | ﹤0.01% | 2637 |
|
|
2021
Q3 | $241K | Buy |
+27,749
| New | +$241K | ﹤0.01% | 2851 |
|
|
2021
Q2 | – | Sell |
-90,479
| Closed | -$1.45M | – | 2672 |
|
|
2021
Q1 | $1.45M | Buy |
90,479
+86,126
| +1,979% | +$1.38M | 0.01% | 1145 |
|
|
2020
Q4 | $201K | Sell |
4,353
-2,689
| -38% | -$124K | ﹤0.01% | 2308 |
|
|
2020
Q3 | $248K | Sell |
7,042
-3,379
| -32% | -$119K | ﹤0.01% | 1701 |
|
|
2020
Q2 | $254K | Buy |
+10,421
| New | +$254K | ﹤0.01% | 2279 |
|